Marco A. Mendoza

Dr. Marco A. Mendoza


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2017 in Nature
Verified
Journal Article
Closed access
PDF file
MMMaja Milanovic
Maja Milanovic
DFDorothy N. Y. Fan
Dorothy N. Y. Fan
DBDimitri Belenki
Dimitri Belenki
JDJ. Henry M. Däbritz
J. Henry M. Däbritz
ZZZhen Zhao
Zhen Zhao
CSClemens A Schmitt
Clemens A Schmitt

1 August 2011 in Cell
Verified
Journal Article
Closed access
SPSilvia Panizza
Silvia Panizza
MMMarco A. Mendoza
Marco A. Mendoza
MBMarc Berlinger
Marc Berlinger
LHLingzhi Huang
Lingzhi Huang
ANAlain Nicolas
Alain Nicolas
FKFranz Klein
Franz Klein

5 June 2011 in Nature Methods
Verified
Journal Article
Closed access
PDF file
PSPattabhiraman Shankaranarayanan
Pattabhiraman Shankaranarayanan
MMMarco A. Mendoza
Marco A. Mendoza
MWMannu Walia
Mannu Walia
LWLi Wang
Li Wang
NLNing Li
Ning Li
HGHinrich Gronemeyer
Hinrich Gronemeyer

4 February 2015 in Genome Research
Verified
Journal Article
Open access
PDF file
RCRonan Chaligné
Ronan Chaligné
TPTatiana Popova
Tatiana Popova
MMMarco A. Mendoza
Marco A. Mendoza
MSMohamed-Ashick M. Saleem
Mohamed-Ashick M. Saleem
DGDavid Gentien
David Gentien
EHEdith Heard
Edith Heard
Disappearance of the Barr body is considered a hallmark of cancer, although whether this corresponds to genetic loss or to epigenetic instability and transcriptional reactivation is unclear. Here we show that breast tumors and cell lines frequently display major epigenetic instability of the inactive X chromosome, with highly abnormal 3D nuclear organization and global perturbations of heterochromatin, including gain of euchromatic marks and aberrant distributions of repressive marks such as H3K27me3 and promoter DNA methylation. Genome-wide profiling of chromatin and transcription reveal modified epigenomic landscapes in cancer cells and a significant degree of aberrant gene activity from the inactive X chromosome, including several genes involved in cancer promotion. We demonstrate that many of these genes are aberrantly reactivated in primary breast tumors, and we further demonstrate that epigenetic instability of the inactive X can lead to perturbed dosage of X-linked factors. Taken together, our study provides the first integrated analysis of the inactive X chromosome in the context of breast cancer and establishes that epigenetic erosion of the inactive X can lead to the disappearance of the Barr body in breast cancer cells. This work offers new insights and opens up the possibility of exploiting the inactive X chromosome as an epigenetic biomarker at the molecular and cytological levels in cancer.

11 October 2011 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
MMMarco A. Mendoza
Marco A. Mendoza
MWMannu Walia
Mannu Walia
MSMartial Sankar
Martial Sankar
HGHinrich Gronemeyer
Hinrich Gronemeyer
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

14 September 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MMMarco A. Mendoza
Marco A. Mendoza
WGWouter Van Gool
Wouter Van Gool
MSMohamed Ashick Mohamed Saleem
Mohamed Ashick Mohamed Saleem
DCDanilo Guillermo Ceschin
Danilo Guillermo Ceschin
HGHinrich Gronemeyer
Hinrich Gronemeyer
The absence of a quality control (QC) system is a major weakness for the comparative analysis of genome-wide profiles generated by next-generation sequencing (NGS). This concerns particularly genome binding/occupancy profiling assays like chromatin immunoprecipitation (ChIP-seq) but also related enrichment-based studies like methylated DNA immunoprecipitation/methylated DNA binding domain sequencing, global run on sequencing or RNA-seq. Importantly, QC assessment may significantly improve multidimensional comparisons that have great promise for extracting information from combinatorial analyses of the global profiles established for chromatin modifications, the bindings of epigenetic and chromatin-modifying enzymes/machineries, RNA polymerases and transcription factors and total, nascent or ribosome-bound RNAs. Here we present an approach that associates global and local QC indicators to ChIP-seq data sets as well as to a variety of enrichment-based studies by NGS. This QC system was used to certify >5600 publicly available data sets, hosted in a database for data mining and comparative QC analyses.